Needham analyst David Saxon has maintained their neutral stance on XRAY stock, giving a Hold rating on August 1.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
David Saxon has given his Hold rating due to a combination of factors impacting DENTSPLY SIRONA’s performance. Although the company’s revenue for the second quarter of 2025 slightly exceeded expectations, and earnings per share were at the upper end of the forecast, the overall revenue growth was not as robust. The company’s efforts in cost reduction have successfully improved profit margins, which is a positive sign.
Despite these improvements, customer surveys indicate that patient volumes are stable, but there is weakness in elective procedures such as implants and orthodontics. While the new management’s approach and the progress in margin enhancement are promising, Saxon believes that the company’s turnaround will require more time, justifying the decision to maintain a Hold rating on the stock.
Saxon covers the Healthcare sector, focusing on stocks such as Cooper Co, DENTSPLY SIRONA, and Staar Surgical. According to TipRanks, Saxon has an average return of -0.7% and a 35.86% success rate on recommended stocks.
In another report released on August 1, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $14.00 price target.